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Aortic valve stenosis (AS) is characterized by left ven-tricular (LV) pressure overload, which may lead to LV 
hypertrophy and compromised coronary flow reserve.1 These 
alterations may cause subendocardial ischemia even in the 
absence of epicardial coronary artery disease and may gradu-
ally affect systolic and diastolic function.2 LV ejection fraction 
(LVEF) is the most routinely used parameter when assessing 
LV systolic function; in AS, it is, however, well known that 
LVEF may remain normal during chronic pressure overload 
despite reduced myocardial contractility by use of preload 
reserve3 or changes in LV geometry.4
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Newer echocardiographic techniques based on automatic 
tracking of movement of speckles on 2-dimensional images 
allow assessment of systolic strain, which reflects longitudi-
nal and radial myocardial function. Global longitudinal sys-
tolic strain (GLS) and strain rate have been shown to correlate 
strongly with invasively assessed myocardial contractility 
parameters such as dP/dT5 and end-systolic pressure–volume 
relation.6 As subendocardial ischemia is primarily known to 
affect longitudinal myocardial fibers,7 the use of longitudinal 
strain analysis may be useful in AS to identify patients with 
reduced contractility despite normal EF. Identification of this 
population is important, as reduced contractility may lead to 
increased long-term mortality despite aortic valve replace-
ment (AVR).
The purposes of this study were, thus, to characterize the 
relationship of GLS and LV remodeling in patients with 
severe AS and to demonstrate the importance of preoperative 
GLS and strain rate on long-term outcome including cardio-
vascular mortality and cardiac hospitalization after AVR in 
patients with AS.
Methods
The present study is a prespecified substudy of a prospective 
 single-center randomized study to evaluate the effect of candesar-
tan compared with conventional treatment on reverse remodeling in 
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consecutive patients undergoing AVR for symptomatic AS.8 The study 
was registered with the National Board of Health and the Danish Data 
Protection Agency and was approved by the local ethical commit-
tee, and all patients gave written informed consent. ClinicalTrials.gov 
Identifier: NCT00294775
Screening and Inclusion
Patients eligible for the study were aged >18 years with symptom-
atic severe AS (estimated aortic valve area<1 cm2) scheduled for 
AVR at Odense University Hospital during the period February 2006 
and May 2008. Patients with LV systolic dysfunction (LVEF<40%), 
renal failure (s-creatinine >220 μmol/L), previous aortic valve sur-
gery, planned additional valve repair/replacement, acute infective 
endocarditis, predominantly aortic valve regurgitation, or treatment 
with an angiotensin-converting enzyme inhibitor or an angiotensin 
receptor blocker at the time of enrolment were excluded. The need for 
AVR was decided by consensus among senior cardiologists, cardiac 
surgeons, and anesthetists not involved in the present study. Of the 
238 patients screened for participation, 49 refused participation in 
the study, 59 met at least 1 exclusion criteria, and 5 did not undergo 
surgery, leaving 125 patients in the study. Patients were divided into 
4 groups according to global strain quartiles.
The severity of preoperative symptoms was evaluated using the 
New York Heart Association (NYHA) functional class for dyspnea 
and the Canadian Cardiovascular Society (CCS) functional class for 
angina.
Ischemic heart disease was defined as a history with prior myo-
cardial infarction, previous revascularization with percutaneous 
coronary intervention (PCI), or coronary artery bypass grafting or 
if preoperative coronary angiography demonstrated significant ste-
nosis requiring coronary artery bypass grafting in addition to AVR.
Echocardiography
All echocardiograms were performed and analyzed by the same op-
erator on a GE Vivid 5 ultrasound machine (GE Medical System, 
Horten, Norway), the day before surgery. All echocardiograms were 
digitally stored and later analyzed completely blinded for all clinical 
and survival data.
Aortic valve area was estimated with quantitative Doppler using 
the continuity equation. The diameter of the LV outflow tract was 
measured 5 mm below the annulus from a zoomed image of the 
LV outflow tract obtained in the parasternal long-axis view. Peak 
flow velocity across the valve was determined in the apical window 
or the echocardiographic window, where the highest peak velocity 
could be obtained by placing the continuous wave Doppler cursor 
as parallel as possible with the flow across the valve. Peak transval-
vular gradient was estimated using the Bernoulli equation. Finally, 
the peak systolic flow velocity in the outflow tract was estimated 
with pulsed-wave Doppler. LVEF was estimated using Simpson’s 
biplane method.9
LV mass was estimated according to the joint recommendations 
of the American (ASE) and European (EAE) associations of echo-
cardiography using Devereux’s.10 LV wall thickness and dimensions 
were estimated from the average of 3 consecutive 2-dimensional im-
ages obtained in the parasternal long-axis view according to guide-
lines. In males, left ventricular mass index (LVMi)> 116 g/m2 and 
in women >100 g/m2 was considered indicative of LV hypertrophy. 
Relative wall thickness was calculated for assessment of LV geom-
etry using the formula 2×PWT/LV diastolic diameter.10
Left atrial volume index (LAVi) was measured in LV end systole in 
the frame preceding mitral valve opening. The volume was measured 
using the biplane area length method and corrected for body surface 
area.
Mitral inflow was assessed in the apical 4-chamber view using 
pulsed-wave Doppler with the sample volume paced at the tips of 
 mitral leaflets during diastole. From the mitral inflow profile, the 
E- and A-wave peak velocities and DT were measured. Doppler 
tissue imaging of the mitral annulus was obtained from the apical 
4- chamber, apical 2-chamber, and apical long-axis views, using a 
sample volume placed in the septal, lateral, anterior, inferior, and 
posterior mitral valve annulus. The e’ velocity from each site and the 
mean value were determined, and the respective E/e’ ratios were de-
rived. For all Doppler recordings, a horizontal sweep of 100 mm/s 
was used; for patients in sinus rhythm, an average of 5 consecutive 
beats were measured, 10 for patients with atrial fibrillation.
GLS was analyzed using EchoPAC PC 08 (GE Medical system, 
Horten, Norway) speckle tracking software 2-D. GLS was deter-
mined as the magnitude of strain at the aortic valve closure, and sys-
tolic strain rate (SRS) was determined as the maximal negative SR 
value during the ejection phase. Both parameters were assessed in all 





lated. Frame rate was kept as high as possible with a minimum frame 
rate of 70/s.
Systemic arterial pressure was measured with the use of an arm 
cuff sphygmomanometer in the right arm with the patient in the su-
pine position, at the same time as the Doppler measurement of stroke 
volume (SV) was measured in the LV outflow tract. The ratio of 
stroke volume index (SVi) to brachial pulse pressure (PP) was used as 
an indirect measure of total systemic arterial compliance: SAC=SVi/
PP.11 The systemic vascular resistance was estimated by the formula 
SVR=(80×MAP)/CO, where MAP is the mean arterial pressure de-
fined as diastolic pressure plus one third of PP and CO is the cardiac 
output.
As a measure of global LV load, we calculated the valvuloarterial 
impedance Z
va
=(SAP+MG)/SVi, where SAP is the systolic arterial 
pressure, MG is the mean transvalvular pressure gradient, and SVi is 
the stroke volume index.11
Plasma N-Terminal Probrain Natriuretic Peptide
Blood samples were collected immediately after the echocardio-
gram, after the subject had been resting recumbent for at least 30 
minutes. Samples were collected in ethylenediamine tetra-acetic 
acid tubes. These were then centrifuged, and plasma samples were 
stored at −80°C for later analysis. NT-proBNP was determined us-
ing an ELECSYS proBNP immunoassay (Roche Diagnostics GmbH, 
Mannheim, Germany).
Clinical Follow-Up
By July 2011, data on outcomes were collected from the Danish 
Personnel Register (survival status) and from discharge notes avail-
able in the Danish admission registry. In case of ambiguous informa-
tion, local hospitals were contacted, and detailed patient charts were 
reviewed.
The main end point for this study was a major adverse cardiac 
event (MACE), defined as cardiovascular mortality and cardiac 
hospitalization due to worsening of heart failure; the secondary end 
point was cardiovascular mortality. End points were ascertained by 
one of the investigators who was blinded to all echocardiographic 
measurements.
Statistics
Data are presented as mean±SD or number and percentages. The dif-
ferences between the groups were tested using ANOVA; categorical 
variables were tested by Fisher exact test. In case of significant differ-
ences between the groups, paired comparisons were performed using 
Tukey range test.
Because of non-Gaussian distribution, NT-pro BNP was logarithm 
transformed. Reproducibility of measurements of GLS was assessed 
by intraclass correlation coefficients. Mortality and event rates were 
calculated using the product limit method and were plotted accord-
ing to the Kaplan–Meier method, and death rates were compared us-
ing the log-rank test. Further estimation of risk was performed using 
Cox proportional hazard models. The overall differences between 
the models were tested by calculating the overall difference in log 
likelihood χ2 between models. The assumptions (proportional hazard 
assumption, linearity of continuous variables, and lack of interac-
tion) were tested and found valid. A P value <0.05 was considered 
significant. STATA/SE 9.0 (StataCorp LP, TX) software was used for 
statistical analysis.
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Results
A total of 125 patients were included in this study; thirty-eight 
patients met the combined end point MACE. Table 1 provides 
baseline clinical and echocardiographic data according to 
MACEs during follow-up. AVR was performed in all patients. 
Coronary artery bypass grafting was performed in 37 (30%) 
patients with no difference between the groups; complete revas-
cularization was achieved in all patients. No difference in the 
size or type of aortic valve prosthesis was seen between groups; 
additionally, the use of β-blockers, calcium channel block-
ers, ACE inhibitors, and diuretics was equal between groups 
preoperatively. There was a trend toward increased age in 
patients experiencing MACEs (75±7 vs. 71±10 years; P=0.06). 
Patients with MACEs had increased occurrence of atrial fibril-
lation (26% vs. 10%; P=0.03), increased levels of NT-proBNP, 
increased LVMi (146±43 vs. 124±38 g/m2), reduced e’
sep veloc-
ity (5.3±1.7 vs. 5.9±1.6 cm/s; P=0.04) and increased LA vol-
ume index (57±18 vs. 45±18 mL/m2; P=0.0009). Longitudinal 
systolic function was reduced in patients with MACEs; global 
longitudinal strain (−13.7±3.8 vs. 16.3±3.4; P=0.0002), s’
sep 
(5.3±1.5 vs. 5.9±1.4 cm/s; P=0.03), and systolic strain rate 
(−0.76±0.22 vs. −0.87±0.18 s−1; P=0.002).
GLS in the complete cohort was −15.5±3.7. GLS was 
−20.0±1.6 in the first quartile, −16.9±0.7 and −14.3±0.9 in the 
2 middle quartiles, respectively, and −10.3±1.4 in the fourth 
quartile. Table 2 shows echocardiographic data distributed 
among GLS quartiles. Aortic valve area and peak aortic 
valve velocity were similar among groups, Z
va
 was signifi-
cantly lower in group 1. LV end-diastolic volume, LV end-
systolic volume and log-NT-proBNP increased across groups 
1 through 4. In group 4, LVEF was significantly lower, and 
LVMi was significantly higher than the other groups. The 
duration of heart failure symptoms prior to surgery was simi-
lar among GLS quartiles (1.9±0.8 vs. 2.2±0.8 vs. 1.9±0.7 vs. 
2.1±0.7 months; P=0.35, data not shown).
Factors Associated With GLS
Reproducibility of measurements of GLS was tested in a sub-
set of 50 patients. The reproducibility was excellent with an 
intraclass correlation coefficient for intraobserver variability 
of 0.93 (CI 0.90–0.96; P<0.001).
Reduced GLS was associated with increased LVMi, relative 
wall thickness, LV end-diastolic volume, and Z
va
 (Table 3). In 
addition, GLS was significantly correlated with SVi (β=−0.08; 
P=0.007), LAVi (β=0.068; P<0.001), LVEF (β=−0.16; 
P<0.001), and log-NT-proBNP (β=1.25; P<0.001). In a multi-
variate regression analysis including the aforementioned vari-
ables, except LAVi and NT-proBNP (because of significant 
colinearity with LVMi), parameters independently associated 




The mean follow-up duration in the total cohort was 3.8±1.5 
years (median 4.0 years). Survival status was available for all 
patients. Overall, there were 29 deaths, 4 in group 1, 6 in group 
2, 6 in group 3, and 13 in group 4. The causes of 4 deaths were 
not because of any cardiac condition (n=2 cancer, n=1 infec-
tious disease, n=1 subarachnoid hemorrhage), and 25 patients 
had a cardiac cause of death (n=15 sudden cardiac death, n=7 
postoperative death, n=2 congestive heart failure, n=1 aortic 
aneurism). Thirty-eight patients met the combined end point 
MACE (n=20 cardiac death, n=18 congestive heart failure).
Overall mortality, cardiac mortality, and MACEs were 
significantly increased in patients with lower global strain 
(estimated 5-year MACEs: first quartile 19% [n=6] / second 
quartile 20% [n=6] / third quartile 35% [n=11] / fourth quar-
tile 49% [n=15]; P=0.04; Figure 1).
Twenty-two patients were still symptomatic at discharge 
(19=NYHA functional class II; n=2 NYHA functional class 
III; n=1 NYHA functional class IV), of which 27% (n=6) met 
the combined end point MACE.
In a univariable Cox regression analysis global strain, 
LAVi, LVMi, LV posterior wall thickness, E/e’, s’
sep, log-
NT-proBNP, and age were predictors of MACEs (Table 
4). In a stepwise Cox model with forward selection of the 
aforementioned variables, except s’
sep (because of signifi-
cant colinearity with GLS), GLS was the sole factor sig-
nificantly associated with MACEs hazard ratio=1.13 (95% 
confidence interval 1.01–1.25), P=0.018. We tested sev-
eral multivariate models in all GLS was significantly asso-
ciated with MACEs and cardiac death (online-only data 
supplement Figures I and II), including a predefined model 
containing EuroScore, known ischemic heart disease, and 
ejection fraction (Table 4). Although ejection fraction was 





Age, y 75±7 71±10 0.06
Sex (male) 24 (63) 55 (63) 0.58
NYHA I/II/III/IV 11/16/10/1 12/49/26/0 0.07
CCS I/II/III/IV 19/15/4/0 44/39/5/0 0.60
Atrial fibrillation 10 (26) 9 (10) 0.03
Diabetes mellitus 2 (6) 9 (28) 0.28
CABG 9 (24) 28 (32) 0.40
Ischemic heart disease 12 (32) 26 (30) 0.55
EuroScore 6.1±1.5 5.6±2.1 0.22
Ejection fraction, % 54±8 54±8 0.64
LV end-diastolic volume, mL 110±36 109±33 0.96
LV end-systolic volume, mL 52±20 51±18 0.80
LVMi, g/m2 146±43 124±38 0.004
LA volume index, mL/m2 57±18 45±18 0.0009
E-velocity, m/s 0.8±0.2 0.8±0.2 0.90
A-velocity, cm/s 1.0±0.3 0.9±0.3 0.09
Deceleration time, ms 202±66 197±56 0.66
E’sep, cm/s 5.3±1.7 5.9±1.6 0.04
S’sep, cm/s 5.3±1.5 5.9±1.4 0.03
Global longitudinal strain −13.7±3.8 −16.3±3.4 0.0002
Systolic strain rate −0.76±0.22 −0.87±0.18 0.002
Log NT-proBNP 6.7±1.2 6.0±1.3 0.006
NYHA indicates New York Heart Association; CCS, Canadian Cardiovascular 
Society; CABG, coronary aortic bypass graft; LV, left ventricular; LVMi, left ven-
tricular mass index; and LA, left atrial.
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not an independent predictor, it was included in multivari-
ate models (Table 4). Nevertheless, GLS was still a signifi-
cant predictor.
Comparing the overall log likelihood χ2 of the predictive 
power of the multivariable model, two models containing GLS 
were statistically superior to models based on age, LVMi, and 
LAVi or EuroScore, ischemic heart disease, and ejection frac-
tion, Figure 2.
Discussion
The main finding in our study is that preoperative longitu-
dinal LV systolic function assessed with speckle tracking 
analyses is significantly associated with long-term postopera-
tive MACEs and cardiac mortality in symptomatic patients 
with severe AS and LVEF>40% after aortic valve surgery. 
Second, we demonstrated that preoperative global strain is 
dependent on LV afterload, LV preload, and the extent of LV 
remodeling.
It is well known that patients with AS have reduced LV 
longitudinal systolic function despite normal LVEF.12–16 In 
hypertension, it has been demonstrated that afterload per se 
affects longitudinal systolic function17 with a compensatory 
increased contribution to ventricular emptying from radial 
LV fibers, thereby maintaining LVEF. In the present study, 
this understanding was extended to patients with AS where 
we found GLS was associated with global LV afterload (Z
va
) 
after adjustment for confounders. This finding agrees with the 
findings of Miyazaki et al who demonstrated that GLS gradu-
ally decreased as AS severity increased.16 A previous study in 
patients with AS demonstrated that coronary flow is severely 
impaired in AS and that increased afterload is the main rea-
son;1 this correlates well with our findings as we have dem-
onstrated that patients with reduced global longitudinal strain 
have decreased systemic arterial compliance, a factor that 
may affect coronary flow.18 Subendocardial ischemia related 
to increased afterload may thus play an important factor. 
However, in addition to increased afterload, AS leads to LV 
remodeling including LV hypertrophy, myocardial fibrosis, 
and altered LV geometry; all factors were potentially capa-
ble of affecting longitudinal systolic function. As postopera-
tive LV reverse remodeling is a slow and not fully reversible 
process,19 structural changes in the myocardium may be of 
greater clinical importance as they may affect postoperative 
prognosis.20









Aortic valve area, cm2 0.9±0.2 0.9±0.3 0.8±0.3 0.8±0.3 0.29
AVmax, m/s 3.8±0.6 3.8±0.8 4.0±0.8 4.1±0.8 0.49
Zva 4.0±1.1* 5.1±1.7 5.1±1.6 5.2±1.4 0.01
Ejection fraction, % 58±8 55±6 55±7 50±7† 0.0001
LVEDV, mL 96±24 103±35 112±30 125±39‡ 0.004
LVESV, mL 41±13 47±16 51±16 63±23† <0.0001
LVMi, g/m2 121±26 121±36 127±34 153±53§ 0.003
IVST, mm 13±2 13±2 13±2 13±3 0.53
LVPWT, mm 12±2 13±2 13±2 14±2‡ 0.001
Relative wall thickness 0.57±0.14 0.58±0.12 0.60±0.11 0.64±0.18 0.14
E wave, m/s 0.8±0.2 0.8±0.2 0.8±0.2 0.8±0.3 0.68
A wave, m/s 1.0±0.3 1.0±0.2 0.9±0.2 0.9±0.4 0.51
Deceleration time, ms 210±52 205±57 191±50 188±73 0.39
E’sep, cm/s 6.2±1.9 5.9±1.4 5.8±1.4 5.0±1.8§ 0.04
Diastolic function 0/1/2/3 3/18/7/2 1/14/11/4 0/16/5/8 1/14/6/9 0.16
LAVi, mL/m2 42±17 45±16 49±17* 59±20‡ 0.001
E/e’sep 13.2±4.0 14.6±4.9 14.1±4.6 17.7±6.5† 0.005
S’sep, cm/s 6.5±1.2 6.1±1.4 5.7±1.1* 4.5±1.5† <0.0001
Stroke volume index, mL 47±11 41±14 39±14 38±12 0.04
Global strain −20.0±1.6 −16.9±0.7 −14.3±0.9 −10.3±1.4
GLS 4-chamber, % −20.2±3.1 −17.3±2.1 −14.8±2.3 −10.7±2.3
GLS 2-chamber, % −19.6±2.7 −16.6±3.2 −14.0±2.6 −10.5±2.0
GLS long axis, % −20.1±3.6 −16.5±2.3 −14.1±2.4 −9.9±2.3
Strain rate S, s−1 −0.99±0.13 −0.92±0.10 −0.82±0.16 −0.59±0.13
Log proNT-proBNP 5.5±1.1 5.9±1.0 6.5±1.2‡ 7.0±1.5‡ <0.0001
LVEDV indicates left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVMi, left ventricular mass index; IVST, interventricular 
septum thickness, LVPWT, LV posterior wall thickness; LAVi, left atrial volume index; and GLS, global longitudinal systolic strain.
*P<0.05 compared with the second, third, and fourth quartiles, †P<0.05 compared with the first, second, third quartiles, ‡P<0.05 compared with the first 
and second quartiles, §P<0.05 compared with the first quartile.
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We demonstrated that GLS was dependent on LV hyper-
trophy and LV geometry, a finding that correlates well with 
previous studies, which have demonstrated that postoperative 
improvement in longitudinal systolic function is dependent on 
regression of LV hypertrophy.12 The mechanism is probably 
increased oxygen consumption of the hypertrophied LV.
To the best of our knowledge, this is the first study to dem-
onstrate that GLS is significantly associated with cardiac mor-
bidity and mortality incremental to conventional risk factors 
in patients undergoing AVR. The link between poor outcome 
and longitudinal LV function could be multiple. Myocardial 
fibrosis has recently gained significant attention, where it has 
been demonstrated to affect postoperative remodeling and 
postoperative outcome.13,21 Weidemann et al demonstrated 
that longitudinal strain was significantly decreased in patients 
with severe myocardial fibrosis, and thus it has been proposed 
that GLS may be used as a noninvasive marker reflecting 
myocardial fibrosis.13 Based on this, it could be speculated 
that reduced GLS may reflect the impact of myocardial fibro-
sis on LV longitudinal systolic function in AS and provide the 
link to poor outcome.
Myocardial fibrosis, however, would also be anticipated to 
be associated with decreased LV compliance and cause dia-
stolic dysfunction. We were unable to detect differences in 
deceleration time or diastolic function, although there was a 
trend toward increased presence of restrictive filling. Whether 
this is because of inherent insensitivity to detect subtle differ-
ences in LV chamber compliance or whether LV compliance 
was unaffected is not clear.
GLS correlated significantly with other well-known risk 
factors for poor outcome after aorta valve replacement includ-
ing LAVi,20 LVMi,20 E/e’,22 and increased NT-proBNP.23 GLS 
was, however, the strongest predictor for postoperative out-
come in our population providing information additional to the 
Figure 1. Survival from adverse cardiac event as a function of the level of global strain unadjusted (A), adjusted for EuroScore, ejection 
fraction, known history of ischemic heart disease (B). GLS indicates global longitudinal systolic strain.
Table 3. Regression Analysis: Factors Associated With Global Strain
Univariable Multivariable R 2=0.36
R β (95% CI) P β (95% CI) P
Age 0.09 0.036 (−0.04 to 0.11) 0.34
Gender 0.75 (−0.6 to 2.1) 0.29
Diabetes mellitus 0.014 (−0.003 to 0.03) 0.10
Aortic valve area −0.16 −2.2 (−4.7 to 0.3) 0.09
Mean gradient 0.16 0.04 (−0.00 to 0.7) 0.06
Zva 0.28 0.7 (0.2 to 1.1) 0.004 0.6 (0.2 to 1.1) 0.005
Ejection fraction −0.33 −0.2(−0.3 to −0.1) <0.001 −0.1 (−0.2 to 0.1) 0.002
LVMi 0.32 0.03 (0.01 to 0.05) <0.001 0.02 (0.01 to 0.04) 0.007
RWT 0.23 6.1 (1.5 to 10.7) 0.01 6.9 (2.3 to 11.3) 0.003
LVEDV 0.35 0.04 (0.02 to 0.06) <0.001 0.02 (0.01 to 0.04) 0.045
LAVi 0.34 0.068 (0.033 to 0.10) <0.001
SAC −0.20 −3.2 (−6.4 to −0.1) 0.048
SVi −0.26 −0.08 (−0.12 to −0.02) 0.007
Log NT-proBNP 0.43 1.25 (0.78 to 1.72) <0.001
Candesartan −0.13 (−1.5 to 1.2) 0.85
Zva indicates valvuloarterial impedance; LVMi, left ventricular mass index; RWT, relative wall thickness; LVEDV, left ventricular end-diastolic  volume; 
LAVi, left atrial volume index; SAC, systemic arterial compliance; and SVi, stroke volume index; .
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aforementioned parameters as well as to traditional risk fac-
tors such as age, gender, diabetes mellitus,24 and EuroScore.23
This may reflect that GLS is affected by both physiology 
and anatomy.
The increased levels of NT-proBNP, higher E/e’, and 
increased LAVi in patients with decreased GLS suggest that 
patients would have had a longer duration of heart failure 
symptoms before surgery; this was, however, not the case 
and this further questions the unambiguity of symptom esti-
mation. This is further challenged by the increased mortality/ 
morbidity seen in patients with reduced global strain, as this 
suggests that surgery should be considered before the onset 
of symptoms has occurred. Although not demonstrated in 
a randomized setting, the benefit of early surgery has been 
Table 4. Univariable and Multivariable Predictors of MACEs
Univariable Multivariable Multivariable
HR (95% CI) P HR (95% CI) P HR (95% CI) P
GLS 1.18 (1.1–1.3) 0.001 1.12 (1.01–1.25) 0.028 1.15 (1.02–1.28) 0.018
LVEF, % 0.98 (0.94–1.03) 0.49 1.03 (0.98–1.08) 0.31
LVEF<50% 1.27 (0.6–2.6) 0.50
Age 1.04 (1.00–1.08) 0.04 1.02 (0.98–1.07) 0.31 1.02 (0.98–1.07) 0.30
EuroScore 1.12 (0.96–1.31) 0.14
Diabetes 1.7 (0.8–3.7) 0.19
IHD 0.76 (0.4–1.5) 0.44
CABG 0.63 (0.3–1.4) 0.24
Mean gradient 1.01 (1.00–1.03) 0.15
NYHA III/IV 1.05 (0.52–2.11) 0.90
LAVi 1.03 (1.01–1.04) <0.001 1.01 (0.99–1.04) 0.18 1.02 (0.99–1.04) 0.15
LVMi 1.01(1.00–1.02) 0.003 1.00 (0.99–1.01) 0.94 1.00 (0.99–1.01) 0.97
RWT 7.7 (0.8–77) 0.08
E/e’avg 1.08 (1.02–1.15) 0.01
Log NT-proBNP 1.46 (1.14–1.86) 0.003
LVEDV 1.00 (0.99–1.01) 0.73
LVESV 1.00 (0.98–1.02) 0.98
LVPWT 7.7 (1.8–33) 0.005
S’sep 0.74 (0.58–0.93) 0.01
Zva 0.87 (0.69–1.09) 0.22
SRs 10.0 (2–50) 0.005
Candesartan 0.67 (0.35–1.28) 0.23
HR indicates hazard ratio; GLS, global longitudinal systolic strain; LVEF, left ventricular ejection fraction; IHD ischemic heart disease; CABG, coronary artery 
bypass grafting; NYHA, New York Heart Association; LAVi, left atrial volume index; LVMi, left ventricular mass index; RWT, relative wall thickness; LVEDV, 
left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVPWT, LV posterior wall thickness; Zva valvuloarterial impedance; and 
SRs, systolic strain rate.
Figure 2. Incremental prognostic information of EuroScore, ejection fraction, ischemic heart disease and global strain in predicting 
 cardiac mortality. Global strain also provided incremental information to age, left ventricular mass index, and left atrial volume index.  
EF indicates ejection fraction; GLS, global longitudinal systolic strain; IHD ischemic heart disease; LAVi, left atrial volume index; and LVMi, 
left ventricular mass index.
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suggested in a study of 622 asymptomatic patients with AS, 
in whom survival was improved in those having AVR, even in 
patients who remained asymptomatic.25 The benefit of early 
surgery has further been suggested in a recent, small random-
ized study.26 Larger studies are, however, warranted.
Study Limitations
The sample size was small with relatively fewer events, which 
make our models unstable with a potential risk of overfit-
ting the models. The present study should be considered as 
hypothesis generating, and clearly, larger studies including 
patients with more subnormal LVEF are warranted. We were 
not able to demonstrate that LVEF is a predictor in AS; this 
possibly reflects that patients with LVEF<40% were excluded. 
The entry criterion for the study was symptomatic AS referred 
for AVR. Because of selection bias, it precludes applicability 
to asymptomatic patients. Future studies should be performed 
on asymptomatic patients to clarify whether our findings also 
apply to a general population with AS.
LV structure was assessed by echocardiography, and no 
histological examinations were performed; thus, we can only 
speculate on the degree of myocardial fibrosis. No direct 
hemodynamic measurements of LV end-diastolic or LA pres-
sure were performed. However, E/e’ is accepted as a well-
validated surrogate in a wide range of patients with cardiac 
disease including AS.27
Conclusions
The present study demonstrates that preoperative longitudi-
nal global strain assessed with speckle tracking analyses is 
significantly associated with long-term postoperative cardiac 
mortality and morbidity, in patients with severe aortic valve 
stenosis and LVEF>40% after aortic valve surgery.
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CLINICAL PERSPECTIVE
Aortic valve stenosis (AS) leads to left ventricular remodeling and compromised coronary flow reserve that gradually affects 
systolic and diastolic function. Left ventricular ejection fraction is the most routinely used parameter when assessing left 
ventricular systolic function. However, it is well known that in AS, ejection fraction may remain normal despite reduced 
myocardial contractility. The use of speckle tracking allows assessment of systolic strain, which reflects longitudinal and 
radial myocardial function. As early myocardial alterations are primarily known to affect longitudinal myocardial fibers, 
the use of longitudinal strain analysis may be useful in AS in identifying patients with reduced contractility despite normal 
ejection fraction. Identification of this population is important, as reduced contractility may lead to increased long-term 
mortality despite aortic valve replacement. We have demonstrated that global strain is independently associated with long-
term postoperative cardiac mortality and morbidity in symptomatic patients with severe aortic valve stenosis and preserved 
ejection after aortic valve surgery. Future studies should be performed on asymptomatic patients to clarify whether patients 
with reduced global strain would benefit from early surgery.
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Supplemental Figure I. Cardiac survival as a function of the level of global strain 
 
 
Supplemental Figure II. Incremental prognostic information of EuroScore, diabetes, left 
atrial volume index and global strain, in predicting cardiac mortality. Global strain also 
provided incremental information to ejection fraction, NT-proBNP and relative wall 
thickness.  
 


